Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor

Koffiekamer« Terug naar discussie overzicht

Marcel Wijma - Stal met medicijnen

5 Posts
| Omlaag ↓
  1. MyOpinion 10 november 2007 20:58
    Adherex And SIOPEL Report Launch Of Phase III Trial Of Sodium Thiosulfate In Children With Hepatoblastoma:
    Adherex Technologies Inc. (ADH | charts | news | PowerRating) and its collaborative partner, the International Childhood Liver Tumour Strategy Group or SIOPEL on Tuesday revealed that the planned Phase III trial of sodium thiosulfate or STS in children with hepatoblastoma has opened for patient enrollment in the United Kingdom.
    According to the company, the multi-center, prospective randomized Phase III clinical trial is expected to enroll about 100 evaluable children with hepatoblastoma, an orphan disease, being treated with cisplatin.

5 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.